首页 | 本学科首页   官方微博 | 高级检索  
     

阿奇霉素联合头孢哌酮钠舒巴坦钠治疗老年肺炎的效果分析
引用本文:木安红. 阿奇霉素联合头孢哌酮钠舒巴坦钠治疗老年肺炎的效果分析[J]. 中国现代药物应用, 2022, 0(1): 126-128
作者姓名:木安红
作者单位:朝阳市第四医院
摘    要:
目的 研究阿奇霉素联合头孢哌酮钠舒巴坦钠治疗老年肺炎的临床效果.方法 94例老年肺炎患者,根据治疗方式不同将其分为研究组与对照组,每组47例.对照组采用阿奇霉素进行治疗,研究组采用阿奇霉素联合头孢哌酮钠舒巴坦钠治疗.对比两组临床疗效、治疗期间不良反应发生情况、临床症状改善时间、治疗前后炎性因子指标.结果 研究组治疗总有...

关 键 词:头孢哌酮钠舒巴坦钠  阿奇霉素  老年肺炎  临床疗效  炎性指标

Effect analysis of azithromycin combined with cefoperazone sodium and sulbactam sodium in the treatment of senile pneumonia
MU An-hong. Effect analysis of azithromycin combined with cefoperazone sodium and sulbactam sodium in the treatment of senile pneumonia[J]. Chinese Journal of Modern Drug Application, 2022, 0(1): 126-128
Authors:MU An-hong
Affiliation:(Chaoyang Fourth Hospital,Chaoyang 122000,China)
Abstract:
Objective To study the clinical effect of azithromycin combined with cefoperazone sodium and sulbactam sodium in the treatment of senile pneumonia. Methods A total of 94 elderly patients with pneumonia were divided into research group and control group according to different treatment methods, with 47 cases in each group. The control group was treated with azithromycin, and the research group was treated with azithromycin and cefoperazone sodium and sulbactam sodium. Both groups were compared in terms of clinical efficacy, occurrence of adverse reactions during treatment, improvement time of clinical symptoms, and inflammatory factors before and after treatment. Results The total effective rate of treatment 97.87% in the research group was higher than 80.85% in the control group, and the difference was statistically significant(P<0.05).The incidence of adverse reactions during treatment 4.26% in the research group was lower than 21.28% in the control group, and the difference was statistically significant(P<0.05). The improvement time of body temperature,sputum color, white blood cell count, and wet rales in the research group was shorter than those in the control group, and the difference was statistically significant(P<0.05). After treatment, the C-reactive protein(2.13±0.05) mg/L and white blood cell(3.52±1.34)×109/L in the research group were lower than(5.56±0.25) mg/L and(6.25±2.52)×109/L in the control group, and the difference was statistically significant(P<0.05). Conclusion The use of azithromycin combined with cefoperazone sodium and sulbactam sodium has significant effect on elderly patients with pneumonia, and it can significantly improve the clinical efficacy and inflammatory response,shorten the recovery time of the disease, reduce the incidence of adverse reactions, has the high security.
Keywords:Cefoperazone sodium and sulbactam sodium  Azithromycin  Elderly pneumonia  Clinical efficacy  Inflammatory index
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号